Assessment Tool for Aseptic Compounding

 

The Assessment Tool for Aseptic Compounding (ATAC) was developed by the Canadian Society of Hospital Pharmacists (CSHP), in collaboration with the Institute for Safe Medication Practices (ISMP) Canada. The items in the tool draw on the best and leading practices articulated in CSHP's publication, Compounding: Guidelines for Pharmacies.

ATAC uses ISMP Canada's platform for Medication Safety Self-Assessments. It consists of 11 key elements that have been deemed to most significantly influence aseptic compounding practices. Each key element is defined by one or more core distinguishing characteristics of an aseptic compounding service. There are a total of 29 core characteristics, supported by over 250 representative assessment items provided to help healthcare teams to evaluate their success with each of the core distinguishing characteristics.

Some of the assessment items refer to "Similar to NAPRA": this note refers to the Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations developed by the National Association of Pharmacy Regulatory Authorities. Any such reference to the NAPRA's Model Standards for Pharmacy Compounding of Non-hazardous Sterile Preparations is for "reference purposes only": no text from NAPRA's Model Standards has been excerpted and incorporated into the ATAC.

Once an assessment is done, an organization can view a summary of the results provided in report card format, export and graph results, compare results against the aggregated database or a group of peers (based on demographic information) as a subset of the aggregate database. (To ensure confidentiality, there must be at least 3 respondents in the aggregate or group of peers to generate graphs.) The results of multiple assessments completed by a site can also be compared to see where improvements have been achieved over time and where challenges remain.

ATAC can help strengthen the medication-use system in the following ways:

  • Increasing awareness of the distinguishing characteristics of a high-quality, reliable aseptic compounding service involving non-hazardous drugs
  • Creating a new baseline of efforts to enhance the safety and quality of aseptic compounding practices in Canadian hospitals and pharmacies
  • Assisting pharmacies, at the site level, in evaluating their efforts over time and in comparison to their peers across Canada

ATAC is not a substitute for CSHP's Compounding: Guidelines for Pharmacies, or for the Model Standards for Pharmacy Compounding of Non-hazardous Sterile Preparations published by NAPRA.

Price

Single assessment: $325. Click here to purchase.

Collaborative pricing: CSHP offers a collaborative model to facilitate the comparison of assessments within a group of 3 to 12 sites (e.g., hospitals within a health region or community pharmacies within a chain). The total price for a collaborative is $325 times the number of sites (from 3 to 12). To purchase ATAC for a collaborative, please contact CSHP at publications@cshp.pharmacy or 613.736.9733 xtn 228.

Acknowledgements: 

CSHP gratefully acknowledges the following people and organizations:

CSHP's Compounding Knowledge Mobilization Task Force
     Cenzina Caliguri
     Catherine Lyder
     Bal Dhillon
     Dana Lyons
     Jill Hardy
     Douglas Sellinger
     Michelle Koberinski
     Marianne Tofan

ISMP Canada team members
     Julie Greenall
     Gary Lee

pfizer_Injectables_WEB_small.jpgfor its financial support of this project. Pfizer Injectables was not involved in the development of the assessment tool.

September 2017

ATAC Offset Small.jpg